BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30145863)

  • 1. MicroRNA-766-3p Inhibits Tumour Progression by Targeting Wnt3a in Hepatocellular Carcinoma.
    You Y; Que K; Zhou Y; Zhang Z; Zhao X; Gong J; Liu Z
    Mol Cells; 2018 Sep; 41(9):830-841. PubMed ID: 30145863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
    Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S; Wang L; Yao B; Liu Q; Guo C
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-519c-3p promotes tumor growth and metastasis of hepatocellular carcinoma by targeting BTG3.
    Wang L; Mo H; Jiang Y; Wang Y; Sun L; Yao B; Chen T; Liu R; Li Q; Liu Q; Yin G
    Biomed Pharmacother; 2019 Oct; 118():109267. PubMed ID: 31387005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
    Zhang N; Chen X
    Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4.
    Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D
    J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
    Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
    Chen Z; Zhuang W; Wang Z; Xiao W; Don W; Li X; Chen X
    J Cell Biochem; 2019 Nov; 120(11):18805-18815. PubMed ID: 31222833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-194 inhibits cell invasion and migration in hepatocellular carcinoma through PRC1-mediated inhibition of Wnt/β-catenin signaling pathway.
    Tang H; Zhao H; Yu ZY; Feng X; Fu BS; Qiu CH; Zhang JW
    Dig Liver Dis; 2019 Sep; 51(9):1314-1322. PubMed ID: 30948333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-542-3p functions as a tumor suppressor via directly targeting survivin in hepatocellular carcinoma.
    Wang XP; Yao J; Guan J; Zhou ZQ; Zhang ZY; Yang J
    Biomed Pharmacother; 2018 Mar; 99():817-824. PubMed ID: 29710480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-34c-3p promotes cell proliferation and invasion in hepatocellular carcinoma by regulation of NCKAP1 expression.
    Xiao CZ; Wei W; Guo ZX; Zhang MY; Zhang YF; Wang JH; Shi M; Wang HY; Guo RP
    J Cancer Res Clin Oncol; 2017 Feb; 143(2):263-273. PubMed ID: 27704267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA hsa_circRNA_104348 promotes hepatocellular carcinoma progression through modulating miR-187-3p/RTKN2 axis and activating Wnt/β-catenin pathway.
    Huang G; Liang M; Liu H; Huang J; Li P; Wang C; Zhang Y; Lin Y; Jiang X
    Cell Death Dis; 2020 Dec; 11(12):1065. PubMed ID: 33311442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS.
    Song J; Wang Q; Luo Y; Yuan P; Tang C; Hui Y; Wang Z
    Int J Clin Exp Pathol; 2015; 8(10):12728-37. PubMed ID: 26722462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.